Prostate Cancer Genetic Risk: What the PATROL Study Reveals

0 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

Published
In today’s episode of UroNurse News, hosted and presented by Vic Senese, RN, BSN, FAUNA, we break down an important and emerging research initiative: the “Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease” (PATROL) study.

This study focuses on improving early detection strategies for individuals at higher inherited risk of developing aggressive forms of Prostate Cancer. Researchers are particularly interested in how genetic predisposition can be used to guide smarter, earlier, and more targeted screening approaches—moving beyond traditional age-based screening alone.

The PATROL study explores how identifying men with increased genetic risk (such as those with inherited cancer susceptibility markers) may allow clinicians to:

Detect clinically significant prostate cancer earlier
Reduce overdiagnosis of low-risk disease
Improve survival outcomes through personalized screening schedules
Tailor follow-up and diagnostic imaging more precisely
As precision medicine continues to evolve, studies like PATROL highlight the growing importance of integrating genetics into routine prostate cancer screening decisions. This approach represents a shift toward risk-based, individualized urologic care, where screening intensity is matched to a patient’s true biological risk profile.

In this episode, we also discuss how this research may influence future clinical guidelines, particularly for men with a family history of prostate cancer or known genetic mutations associated with higher risk.

Categoria
Urology
Commenta per primo questo video.

Prossimo